Trial Search Results

Thromboelastography to Assess Hemostatic Changes in Patients Undergoing Elective Cesarean Delivery.

The purpose of the study is to assess the coagulation changes that occur in patients undergoing elective Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Phase:

N/A

Eligibility


Inclusion Criteria:

   - All obstetric patients with singleton pregnancies admitted to the labor and delivery
   unit at Lucile Packard Hospital who undergo elective Cesarean delivery.

   - We will select 100 healthy ASA 1 patients with singleton pregnancies who are scheduled
   for uncomplicated elective Cesarean delivery, with no anticipated risk of obstetric
   hemorrhage.

Exclusion Criteria:

   - Patients with underlying coagulation disorders.

   - Patients with thrombocytopenia.

   - Patients with pregnancy-induced hypertension, pre-eclampsia.

   - Patients requiring the following medications prior to surgery: NSAIDS, aspirin,
   anticoagulants.

   - Patients requiring non-elective Cesarean delivery.

   - Patients with significant obstetric or medical disease.

   - No patients <18 years of age will be recruited.

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

Female

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Alexander Butwick
Not Recruiting